Practice Guideline Track on Atrial Fibrillation

Guidelines into Practice

Topic(s):

Cardiovascular Pharmacology and Pharmacotherapy

Invasive Electrophysiology and Ablation

Atrial Fibrillation

Contributor: Special thanks to Dipak Kotecha

Based on the ESC Clinical Practice Guidelines on Atrial Fibrillation (Management of) 2016

Webinars on this topic

ESC webinar on "New ESC guidelines for atrial fibrillation: future trends for AF and its neurological complications, the impact of anticoagulation and ablation" streamed live on 15 December 2016: Watch the recording.

Part 1 - Overview of the Guidelines

Session title	Slides	Webcast
ESC Clinical Practice Guidelines: Atrial fibrillation - Part 1
ESC Clinical Practice Guidelines: Atrial fibrillation - Part 2
First presentation of atrial fibrillation: Initial approach, goals, and expectations
The atrial fibrillation heart team approach to stroke prevention: risk stratification and stroke prevention
The atrial fibrillation heart team approach to stroke prevention: managing complications
The atrial fibrillation heart team approach to rate control
The atrial fibrillation heart team approach to antiarrhythmic drugs and catheter ablation
The atrial fibrillation heart team approach to atrial fibrillation surgery
Meet the Guidelines Task Force - Atrial fibrillation

Part 2 - Topics in focus

Topic/Section	Session title	Slides	Webcast
Screening for atrial fibrillation to prevent stroke	Atrial fibrillation Symposium joint with the Lancet
Rate control	Atrial fibrillation Symposium joint with the Lancet
Treating low-risk patients with nonvalvular AF	Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry
Early mortality in newly diagnosed nonvalvular AF	Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry
State of the art in catheter ablation of atrial fibrillation	Can we maintain sinus rhythm by catheter ablation?
Are you still afraid about bleeding risk of antithrombotic therapy in atrial fibrillation?	Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR
ESC-EURObservational Research Programme: In-hospital and 1-year follow-up of the Long-term Atrial Fibrillation Ablation Registry, Conducted by the European Heart Rhythm Association	Registries atrial fibrillation
Association of Inappropriate Dosing of Non-Vitamin K Oral Anticoagulants and Risk of Adverse Events: Results from the ORBIT-AF II Registry	Registries atrial fibrillation
State of the art in treatment of acute coronary syndrome patients in need of oral anticoagulation	Challenges with anticoagulants and antithrombotics in acute coronary syndrome
How to define non-valvular atrial fibrillation?	Atrial fibrillation in clinical practice
Heart failure and atrial fibrillation: which comes first?	Atrial fibrillation in clinical practice
The AF epidemic and AF ablation treatment options in 2016: a clinical evidence review	Creating a new landscape in AF ablation and the impact on clinical practice
Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines	Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications
Anticoagulation in patients with atrial fibrillation: challenges with continuing protection from hospital to home	Practical management of patients with atrial fibrillation – Individualised approaches to stroke prevention
Day-to-day management of patients with atrial fibrillation on non-VKA oral anticoagulant therapy – Practical perspectives	Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation
Gender differences in clinical presentation and predictors of one-year outcomes in atrial fibrillation	Clinical features and management of atrial fibrillation
Ideal AF ablation candidate and when do I refer?	Creating a new landscape in AF ablation and the impact on clinical practice
The management of patients with atrial fibrillation and renal impairment – Practical perspectives	Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation

Show navigation Hide navigation

Practice Guideline Track on Atrial Fibrillation

Guidelines into Practice

Webinars on this topic

Part 1 - Overview of the Guidelines

Part 2 - Topics in focus

Clinical cases on this topic